| Upcoming events on NOVAVAX, INC. |
|
| 03/01/21 | | FY 2020 Earnings Release (Projected) |
| 05/12/21 | | Q1 2021 Earnings Release (Projected) |
| 08/10/21 | | Interim 2021 Earnings Release (Projected) |
| 11/10/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on NOVAVAX, INC. |
|
| 01/11/21 | 08:20am | | JP Morgan Healthcare Conference |
| 01/08/21 | 11:00am | | Biotech Showcase Investor Conference |
| 12/03/20 | 02:15pm | | Evercore ISI HealthCONx Conference |
| 12/02/20 | | Investor Meeting |
|
| Upcoming sector events for NOVAVAX, INC. |
|
|
| |
|
| Past sector events for NOVAVAX, INC. |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 36,3
38,8
-6,5% | 15,4
15,3
0,26% | 31,2
28,7
8,5% | 34,3
35,3
-2,8% | 18,7
11,8
58% |
520
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
|
| -154
-149
-3,8% | -166
-158
-4,6% |
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -157
-119
-32% | -269
-273
1,5% | -172
-168
-2,1% | -174
-172
-1,3% | -130
-121
-7,5% |
-306
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -157
-117
-34% | -280
-284
1,5% | -184
-180
-2,3% | -185
-182
-1,4% | -133
-128
-3,9% |
-340
|
Net income
M $ |
Released
Forecast
Spread | -157
-117
-34% | -280
-285
1,6% | -184
-180
-2,0% | -185
-182
-1,4% | -133
-130
-2,4% |
-314
|
EPS
$ |
Released
Forecast
Spread | -12,0
-8,96
-34% | -20,6
-21,0
2,0% | -12,6
-12,4
-1,5% | -10,0
-10,2
2,4% | -5,51
-5,42
-1,6% |
-5,49
| | Announcement Date | 02/29/2016 | 02/27/2017 | 03/14/2018 | 03/18/2019 | 03/11/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 10,8
10,0
7,6% | 7,74
9,63
-20% | 6,13
7,09
-14% | 3,98
4,60
-13% | 3,36
3,06
9,5% | 2,51
3,32
-24% | 8,82
2,98
195% | 3,38
1,93
75% | 35,5
39,6
-10% | 157
231
-32% |
324
|
764
|
807
|
852
|
797
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -42,0
-43,0
2,2% | -41,9
-46,0
9,0% | -46,5
-44,2
-5,3% | -40,2
-45,2
11% | -36,7
-35,0
-4,9% | -24,0
-20,4
-18% | -28,7
-24,1
-19% | -22,9
-33,7
32% | -17,0
-16,8
-1,4% | -194
113
-272% |
-71,9
|
327
|
317
|
411
|
446
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -44,5
-45,7
2,6% | -44,6
-48,8
8,6% | -49,3
-46,7
-5,5% | -43,2
-46,3
6,6% | -39,6
-37,9
-4,6% | -18,0
-23,3
23% | -31,8
-24,6
-29% | -25,9
-36,3
29% | -17,5
-17,7
0,99% | -197
88,1
-324% |
-99,4
|
-98,3
|
-98,7
|
487
|
811
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -44,5
-45,7
2,6% | -44,6
-48,8
8,6% | -49,3
-46,8
-5,4% | -43,2
-46,4
6,9% | -39,6
-38,3
-3,5% | -18,0
-20,7
13% | -31,8
-27,0
-18% | -25,9
-36,9
30% | -17,5
-35,0
50% | -197
109
-280% |
-73,8
|
246
|
239
|
374
|
380
|
Net income
$ |
Released
Forecast
Spread | -2,40
-2,46
2,6% | -2,40
-2,52
4,8% | -2,60
-2,39
-9,0% | -2,20
-2,26
2,6% | -1,69
-1,59
-6,4% | -0,74
-0,92
19% | -1,13
-1,05
-7,9% | -0,58
-0,71
19% | -0,30
-0,53
44% | -3,21
1,73
-285% |
-1,20
|
2,44
|
2,41
|
3,37
|
3,87
| | Announcement Date | 08/08/2018 | 11/07/2018 | 03/18/2019 | 05/02/2019 | 08/07/2019 | 11/07/2019 | 03/11/2020 | 05/11/2020 | 08/10/2020 | 11/09/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
Logistics firms reap "vaccine economy" benefits as EU gears up for roll-out |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
